American Heart Journal
Volume 157, Issue 1 , Pages 149-155 , January 2009

Three-year clinical outcome after primary stenting of totally occluded native coronary arteries: A randomized comparison of bare-metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (Primary Stenting of Totally Occluded Native Coronary Arteries [PRISON] II study)

  • Braim M. Rahel, MD, PhD

      Affiliations

    • Department of Interventional Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands
    • ,
  • Gerrit J. Laarman, MD, PhD

      Affiliations

    • Department of Interventional Cardiology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands
    • ,
  • Johannes C. Kelder, MD

      Affiliations

    • Department of Research and Statistics, St. Antonius Hospital Nieuwegein, The Netherlands
    • ,
  • Juriën M. ten Berg, MD, PhD

      Affiliations

    • Department of Interventional Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands
    • ,
  • Maarten J. Suttorp, MD, PhD, FACC

      Affiliations

    • Department of Interventional Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands
    • Corresponding Author InformationReprint requests: Maarten J. Suttorp, MD, PhD, FESC, FACC, Department of Interventional Cardiology, St. Antonius Hospital Nieuwegein, Koekoekslaan 1, 3435 CM Nieuwegein, The Netherlands.

Received 22 May 2008 ,Accepted 20 August 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The PRISON II trial is registered with clinicaltrials.gov number NCT 00258596.

PII: S0002-8703(08)00746-1

doi: 10.1016/j.ahj.2008.08.025

American Heart Journal
Volume 157, Issue 1 , Pages 149-155 , January 2009

Article Tools

* Image Usage & Resolution